Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial

Anne Boerekamps, Anja De Weggheleire, Guido E van den Berk, Fanny N. Lauw, Mark A. A. Claassen, Dirk Posthouwer, Wouter F.W. Bierman, Sebastiaan Hullegie, Stephanie Popping, David van de Vijver,

˜The œLancet. Gastroenterology & hepatology · 2019 · 43 citations · 17 references

DOIFull text

Open access

Concepts

References

17